Skip to main
OHI
OHI logo

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc has raised its 2025 Funds From Operations (FFO) estimates, with the projection increasing to $2.81 per share from $2.78 per share, reflecting stronger investment volume than previously anticipated. The company also adjusted its normalized FFO estimate upwards to $2.95 per share from $2.89 per share after excluding non-recurring items, indicating improved operational performance. Additionally, the stock has demonstrated robust market performance, achieving a 12% year-to-date increase, significantly outperforming the VNQ index, and is trading near the higher end of its 10-year valuation range.

Bears say

Omega Healthcare Investors Inc faces a negative outlook primarily due to ongoing challenges faced by operators within the long-term healthcare sector, impacting the company's operational stability and attractiveness. Despite a slight increase in the 2026 adjusted funds from operations (FFO) estimate to $3.22 per share, this figure remains marginally above the consensus forecast of $3.10 per share, suggesting limited upside potential given the current operator struggles. The company’s relative valuation also raises concerns, contributing to an overall cautious stance on its financial prospects.

OHI has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 8 analysts, OHI has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.